Perioperative and intermediate outcomes of patients with pulmonary embolism undergoing catheter-directed thrombolysis vs percutaneous mechanical thrombectomy

Keyphrases

• Pulmonary Embolism 100%
• Catheter-directed Thrombolysis 100%
• Percutaneous Mechanical Thrombectomy 100%
• Confidence Interval 80%
• Odds Ratio 50%
• All-cause Mortality 40%
• Hazard Ratio 30%
• Right Heart Failure 30%
• Emergency Department Visits 30%
• Chronic Pulmonary Hypertension 30%
• Respiratory Failure 20%
• Blood Transfusion 20%
• Safety Profile 20%
• Myocardial Infarction 20%
• Pulmonary Hypertension 20%
• Gastrointestinal Bleeding 20%
• Acute Respiratory Failure 20%
• Functional Outcome 10%
• Comorbidity 10%
• Low Dose Rate 10%
• Postoperative Complications 10%
• Composite Outcome 10%
• Retrospective Cohort Study 10%
• Bleeding Events 10%
• Bleeding Complications 10%
• Intracranial Hemorrhage 10%
• Catheter-directed 10%
• Massive Pulmonary Embolism 10%
• Thrombolytic Therapy 10%
• 5-year Outcomes 10%
• Failure Hazard 10%
• Bleeding Risk 10%
• Data Networks 10%
• Acute Pulmonary Hypertension 10%
• Acute Pulmonary Embolism 10%
• Propensity Score Matching 10%
• Catheter Intervention 10%
• Heart Disease Diagnosis 10%
• Procedural Safety 10%
• January 2017 10%
• Chronic Thromboembolic Pulmonary Hypertension (CTEPH) 10%
• Mechanical Thrombectomy Devices 10%
• TriNetX 10%
• Federated Data 10%
• Acute Cor Pulmonale 10%
• Chronic Pulmonary Embolism 10%
• Respiratory Emergencies 10%
• Submassive Pulmonary Embolism 10%
• Periprocedural MI 10%

Medicine and Dentistry

• Blood Clot Lysis 100%
• Pulmonary Embolism 100%
• Mechanical Thrombectomy 100%
• Odds Ratio 50%
• All Cause Mortality 40%
• Emergency Department 30%
• Pulmonary Hypertension 30%
• Hazard Ratio 30%
• Heart Right Ventricle Failure 30%
• Chronic Pulmonary Hypertension 30%
• Bleeding 20%
• Respiratory Failure 20%
• Blood Transfusion 20%
• Myocardial Infarction 20%
• Ciclonicate 20%
• Acute Respiratory Failure 20%
• Postoperative Complication 10%
• Retrospective Cohort Study 10%
• Fibrinolytic Therapy 10%
• Cerebral Hemorrhage 10%
• Acute Pulmonary Embolism 10%
• Pulmonary Heart Disease 10%
• Chronic Thromboembolic Pulmonary Hypertension 10%
• Comorbidity 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Lung Embolism 100%
• All Cause Mortality 66%
• Pulmonary Hypertension 50%
• Chronic Pulmonary Hypertension 50%
• Heart Right Ventricle Failure 50%
• Bleeding 33%
• Heart Infarction 33%
• Respiratory Failure 33%
• Ciclonicate 33%
• Acute Respiratory Failure 33%
• Fibrinolytic Agent 16%
• Cohort Study 16%
• Brain Hemorrhage 16%
• Postoperative Complication 16%
• Chronic Thromboembolic Pulmonary Hypertension 16%
• Comorbidity 16%
• Cor Pulmonale 16%